Swiss pharma giant Roche Holding AG (RHHBY) posted strong growth in the third quarter. Sales increased 6% year over year to CHF 15.1 billion and were up 9% at constant exchange rates (CER).Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The company reports under two divisions — Pharmaceuticals and Diagnostics. All growth rates mentioned below are on a year-over-year basis and at CER.Total sales increased 6% in the first nine months of 2024 to CHF 45 billion. Excluding COVID-19-relat ...